Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New oleandomycin 9-oximes. Synthesis, characterization and biological activity

G Lazarevski1, G Kobrehel, S Dokić

  • 1PLIV--Pharmaceutical, Chemical, Food and Cosmetic Industry, Research Institute, Zagreb, Croatia.

The Journal of Antibiotics
|March 1, 1994
PubMed
Summary

Novel oleandomycin 9-oximes were synthesized and tested for antibacterial activity. The 8(R)-isomer derivative demonstrated significant in vitro potency, advancing to further studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical symptoms and surgical outcome of colloid cysts of the third ventricle: A multicenter retrospective study.

Brain & spine·2025
Same author

Lymphatic drainage map of the head and neck skin squamous cell carcinoma detected by sentinel lymph node biopsy.

European review for medical and pharmacological sciences·2021
Same author

Toxicity study of DE-EDCP as a potential drug for cancer therapy: Toxicity profile of DE-EDCP.

Human & experimental toxicology·2018
Same author

Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Same author

Strengthening early warning function of surveillance in the Republic of Serbia: lessons learned after a year of implementation.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Same author

Measles and rubella elimination in the WHO Region for Europe: progress and challenges.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Organic Synthesis

Background:

  • Oleandomycin is a macrolide antibiotic with established antibacterial properties.
  • Modifications of existing antibiotics can lead to compounds with improved efficacy or altered pharmacokinetic profiles.

Purpose of the Study:

  • To synthesize novel oleandomycin 9-oxime derivatives.
  • To evaluate the in vitro antibacterial activity of these new compounds.
  • To compare the activity of novel oximes with the parent oleandomycin.

Main Methods:

  • Synthesis of oleandomycin 9-oximes.
  • Characterization using spectroscopic data (e.g., NMR, Mass Spectrometry) and X-ray crystallography.
  • In vitro antibacterial activity assays against relevant microbial strains.

Related Experiment Videos

Main Results:

  • A series of novel oleandomycin 9-oximes were successfully prepared and characterized.
  • 8(R)-methyloleandomycin-9-oxime (compound 9) exhibited the most potent in vitro antibacterial activity among the tested derivatives.
  • The 8(S)-isomer (compound 10) showed significantly lower potency.
  • Preliminary pharmacokinetic data for compound 9 supported its observed activity.

Conclusions:

  • The synthesis of oleandomycin 9-oximes provides a new class of potential antibacterial agents.
  • Stereochemistry at the 8-position is critical for antibacterial potency, with the (R)-configuration being superior.
  • Compound 9 is a promising candidate for further investigation and development as an antibacterial drug.